We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zika Vaccine Shows Protective Efficacy in Monkeys

News   Dec 06, 2018 | Original story from the University of Hawai'i at Manoa

 
Zika Vaccine Candidate Effective in Preclinical Trials

Zika virus results in neurological complications in babies born from infected mothers. The immunogenicity and protective efficacy of a recombinant subunit vaccine candidate has been demonstrated in mice, and in long-tailed macaques (Macaca fascicularis, also known as the crab-eating macaque). Image credit: Mr. Theklan.

 
 
 

RELATED ARTICLES

Male Birth Control Pill Passes Human Safety Tests

News

A new male birth control pill passed tests of safety and tolerability when healthy men used it daily for a month, and it produced hormone responses consistent with effective contraception, according to researchers at two institutions testing the drug.

READ MORE

Twin Registry Used to Reveal Autoimmune Drivers

News

Data from the world’s largest twin registry shows that the risk of developing seven autoimmune diseases is largely inherited, but that some diseases are more closely related than others.

READ MORE

Squishing Blood Stem Cells Could Facilitate Harvest for Transplants

News

Modulating blood-forming stem cells’ stiffness could possibly facilitate mobilization procedures used for stem cell-based transplants. Temporary squishiness could help drive blood-forming stem cells out of the bone marrow and into the blood.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE